Jim Simons Gossamer Bio, Inc. Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 671,600 shares of GOSS stock, worth $604,440. This represents 0.0% of its overall portfolio holdings.

Number of Shares

671,600

Previous 997,001 32.64%

Holding current value

$604,440

Previous $910,000 12.97%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$0.8 - $1.51 $260,320 - $491,355	-325,401 Reduced 32.64%	671,600 $792,000
Q4 2023 Feb 13, 2024	BUY	$0.48 - $1.08 $478,560 - $1.08 Million	997,001 New	997,001 $910,000
Q3 2022 Nov 14, 2022	SELL	$7.21 - $14.88 $238,651 - $492,528	-33,100 Reduced 48.04%	35,800 $429,000
Q2 2022 Aug 12, 2022	SELL	$5.97 - $9.97 $377,304 - $630,104	-63,200 Reduced 47.84%	68,900 $577,000
Q1 2022 May 13, 2022	BUY	$8.44 - $12.49 $746,096 - $1.1 Million	88,400 Added 202.29%	132,100 $1.15 Million

Q4 2021 Feb 11, 2022	BUY	$10.12 - $14.07 $442,243 - $614,859	43,700 New	43,700 $494,000
Q2 2021 Aug 13, 2021	SELL	$8.0 - $9.75 $1.2 Million - $1.46 Million	-150,000 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$8.63 - $10.94 $283,064 - $358,832	-32,800 Reduced 17.94%	150,000 $1.39 Million
Q4 2020 Feb 10, 2021	SELL	$8.3 - $13.59 $1.27 Million - $2.08 Million	-152,800 Reduced 45.53%	182,800 $1.77 Million
Q3 2020 Nov 13, 2020	SELL	$11.3 - $14.75 $316,400 - $413,000	-28,000 Reduced 7.7%	335,600 $4.17 Million
Q2 2020 Aug 13, 2020	BUY	$9.52 - $15.98 $2.53 Million - $4.25 Million	266,138 Added 273.07%	363,600 $4.73 Million
Q1 2020 May 14, 2020	BUY	$8.0 - $15.48 $779,696 - $1.51 Million	97,462 New	97,462 $989,000

Others Institutions Holding GOSS

# of Institutions

114

Shares Held

190M

Call Options Held

405K

Put Options Held

490K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $84.6M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account